Navigation Links
Omthera Announces Waiver of Lock-Up Restriction
Date:7/11/2013

ould be deemed forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions and uncertainties that may cause actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements, and you should not place undue reliance on these statements. Some of the factors that could cause actual results to differ materially from current expectations are: the ability to consummate the proposed transaction; any conditions imposed on the parties in connection with the consummation of the proposed transaction; the failure of the Company's stockholders to approve the proposed transaction; the ability to obtain regulatory approvals of the proposed transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the agreement relating to the proposed transaction; the Company's ability to maintain relationships with employees and third parties following announcement of the proposed transaction; the ability of the parties to satisfy the conditions to the closing of the proposed transaction; the risk that the proposed transaction may not be completed in the time frame expected by the parties or at all; and the risks that are described from time to time in the Company's reports filed with the SEC, including the Prospectus, in other of the Company's filings with the SEC from time to time, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and on general industry and economic conditions. If the proposed transaction is consummated, our stockholders will cease to have any equity interest in the Company and will have no right to participate in its earnings and future growth. The Company disclaims any intention or obligation to update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

Omthera Contact: 
Christian Schade
Ex
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
2. Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm
3. Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
4. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
5. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
6. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
7. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
8. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
11. UM Ventures Announces Collaboration Between UM School Of Medicines Dr. Frank Robb and Fina Biosolutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... PARK, Calif. , Nov. 17, 2014 ... company in the emerging field of regenerative medicine, today ... President of Research and Development, will participate in a ... for Regenerative Medicine (CIRM) discussing the latest progress in ... The CIRM Google Hangout session is scheduled for ...
(Date:11/17/2014)... Wilson Therapeutics AB, a development stage biopharmaceutical company, ... study to evaluate efficacy and safety of its lead ... disorder and designated orphan disease, in which the body ... delighted to proceed with this important clinical study in ... development program for WTX101," said David Clark , ...
(Date:11/17/2014)... 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ... their 2013 collaboration, option, and license agreement to co-develop ... as their research collaboration in prostate cancer. All of ... the product to other parties, will be returned to ... phase I clinical trial in the first half of ...
Breaking Medicine Technology:Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 2Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 3Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 4Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 5
... NEW YORK, June 2, 2011 Citeline, the world,s ... recently completed a comprehensive review of clinical trial starts ... patterns in drug development. Over the one-year review period ... trials were initiated in the oncology sector, more than ...
... Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today ... Trademark Office of Patent Application Serial No. 12/549458 ... This follows the UK issuance which was granted ... patent estate. The patent covers the ...
Cached Medicine Technology:Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 2Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 3Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
(Date:11/17/2014)... A Diet Doc in-house clinical study ... are turning back the clock on aging, looking younger ... the company has recently added their prescription anti-aging human ... prescription and non-prescription diet products and healthy living supplements. ... best anti-aging human growth hormone therapy to their ...
(Date:11/17/2014)... Oskaloosa, IA (PRWEB) November 17, 2014 ... featured in an upcoming episode of American Farmer airing ... Tuesday at 8:30 am ET on RFD-TV. , World ... organic plant based proteins. World Food’s unique system provides ... seed to protein ingredients. , This segment will educate ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 QuickChek customers ... their September “Dog Tag” Promotion. In total, ... Hope For The Warriors® in support of military families ... is a national nonprofit dedicated to restoring a sense ... for our service members and our military families. ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 For the ... specialist used DNA sequencing from a single cell extracted ... that ran in the father’s family. Double-board certified expert ... Springs and Newport Beach, then implanted only the healthy ... , “The world of In Vitro Fertilization has taken ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 Wright & ... Miami ordered Boston Scientific Corp. to pay a total ... who filed bladder mesh lawsuits after they suffered injuries ... company’s Pinnacle transvaginal mesh implant. Bloomberg reported that jurors ... defectively designed and the company failed to warn physicians ...
Breaking Medicine News(10 mins):Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:American Farmer to Feature World Food Processing in 2015 Series 2Health News:QuickChek Gives Big Support to Hope For The Warriors One Dollar at a Time 2Health News:IVF Specialist From American Reproductive Centers Performs World's First DNA Sequencing On Single Cell So Defected Genes Won't Be Passed To Future Generations 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 3Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 4
... Feb. 1 (HealthDay News) -- Among injection drug users, new ... two decades, but the number of new infections from the ... new study reports. The findings suggest that efforts -- ... to prevent blood-borne transmission of infectious diseases have been successful ...
... February 1, 2011 While the overall death rate for ... to have higher death rates and shorter survival of any ... The findings come from Cancer Facts & Figures for African ... two years by the American Cancer Society. The higher ...
... circulating DNA may indicate faster progression of lung cancer ... in the February edition of the Journal of ... Association for the Study of Lung Cancer (IASLC). ... presented more free DNA in the blood than healthy ...
... , MONDAY, Jan. 31 (HealthDay News) -- X-rays, CT scans ... back pain, but often these tests are unnecessary, suggests new ... more, these imaging tests have the potential to cause harm ... -- such as a bulging disc -- that may not ...
... Steven Reinberg HealthDay Reporter , MONDAY, Jan. 31 ... having a stroke, they appear to have better odds of ... This finding might seem odd since conventional wisdom says black ... medical care in general. However, the same trend has been ...
... services that supports California,s low-income, disabled elderly is fragile, ... independent lives in their own homes, according to a ... Research. This policy note reports the ... lives and challenges encountered by several dozen representative older ...
Cached Medicine News:Health News:Infectious Disease Experts Call for More Focus on Hepatitis C 2Health News:Race gap narrows for some cancers in African-Americans; continues to increase for others 2Health News:Race gap narrows for some cancers in African-Americans; continues to increase for others 3Health News:High levels of circulating DNA may signal faster progression of lung cancer 2Health News:Most X-Rays, Scans Unnecessary for Acute Low Back Pain 2Health News:Most X-Rays, Scans Unnecessary for Acute Low Back Pain 3Health News:Survival After Stroke Better for Blacks 2Health News:Survival After Stroke Better for Blacks 3Health News:Aging safely at home? California's disabled elderly are barely holding on 2Health News:Aging safely at home? California's disabled elderly are barely holding on 3
... The Vitros 250 is ... meet requirements in multiple environments ... large hospitals, clinics and satellite ... features on-board dilution, and can ...
The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
... The Bayer Immuno 1 provides ... immunoassay instrument with over 50 ... endocrinology, tumor marker, therapeutic drug, ... can be performed on a ...
Medicine Products: